SF0426OA6643/072026
13/07/2028
Active ingredient:
Orlistat 120 mg.
Therapeutic indications:
Indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMl) ≥ 30 kg/m2, or overweight patients (BMI ≥28 kg/m2) with associated risk factors.
Dosage form
Capsules.
Active ingredient:25 mg diclofenac sodium Therapeutic indications:indicated for Relieving...
Read More
Active ingredient:Ondansetron 4 mg. Therapeutic indications:Indicated for the management...
Read More
Factory Locations
Quick Links
© 2024 All rights reserved @PHARO PHARMA
Terms and Conditions | Privacy Policy
